No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
913 |
4. Check minimum number of eventsNone |
913 |
5. Include endpointsNone |
913 |
6. Filter based on genotype QC (FinnGen only) |
824 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Similar endpoints
↥List of similar endpoints to
Patent foramen ovale
based on the number of shared cases.
Similar with more cases:
- Septal defects
- Congenital malformations of cardiac septa
- Congenital malformations of heart and great arteries
- Congenital malformations of the circulatory system
- Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 824 | 417 | 407 |
| Unadjusted period prevalence (%) | 0.17 | 0.15 | 0.19 |
| Median age at first event (years) | 50.89 | 48.30 | 53.54 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 865
- Matched controls
- 8649
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
I63.4
ICD-10 Finland
Cerebral infarction due to embolism of cerebral arteries
46.3
307.7
227
66
Q21.11
ICD-10 Finland
Paten or persistent foramen ovale
+∞
307.7
864
*
FFC22
NOMESCO Finland
Percutaneous transluminal closure of ostium secundum type ASD
220.7
307.7
176
10
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
21.9
307.7
368
283
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
22.3
307.7
307
208
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
39.8
307.7
500
288
Q21.10
ICD-10 Finland
Persistent ostium secundum
37.7
216.3
137
43
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
6.1
156.7
444
1267
B01AA03
ATC
warfarin; systemic
6.8
140.3
276
554
B01AC04
ATC
clopidogrel; oral
6.5
129.3
267
558
FFC42
NOMESCO Finland
Percutaneous closure of patent foramen ovale
+∞
127.3
119
*
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
5.7
127.0
321
807
XF620
NOMESCO Finland
Examination of circulation with color method
58.5
124.0
70
13
AA1AD
NOMESCO Finland
CT of head and brain
4.6
106.3
392
1314
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
8.0
103.9
156
231
XA800
NOMESCO Finland
Neuropsychological investigation
6.9
97.9
172
301
AA5BD
NOMESCO Finland
CT of cerebral ischaemia
15.1
92.4
84
61
B01AC30
ATC
platelet aggregation inhibitors excl. heparin - combinations
9.5
91.6
116
139
R4150
NOMESCO Finland
Neuropsychological rehabilitation
24.2
87.1
63
28
PA2AE
NOMESCO Finland
Ultrasound examination of brain artery
232.2
82.9
84
*
G45.1
ICD-10 Finland
Carotid artery syndrome (hemispheric)
10.9
78.5
88
89
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.8
77.7
552
2760
PA7AD
NOMESCO Finland
CT angiography of head and neck vasculature
9.3
73.3
93
111
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
4.5
65.6
188
500
C10AA05
ATC
atorvastatin; oral
3.3
64.9
429
1987
XF400
NOMESCO Finland
ECG with 12 standard connections
3.9
64.8
248
814
I63.3
ICD-10 Finland
Cerebral infarction due to thrombosis of cerebral arteries
10.4
62.7
72
75
AA5PD
NOMESCO Finland
CT examination of brain pefusion
24.3
61.2
44
19
K90
ICPC
Stroke/cerebrovascular accident
11.4
58.1
62
58
TPX22
NOMESCO Finland
Intravenous arterial thrombolysis
82.0
54.8
61
8
Q21.00
ICD-10 Finland
Multiple ventricular septal defect
24.0
54.0
39
17
R4120
NOMESCO Finland
Occupational therapy
4.7
53.1
136
328
Q21.19
ICD-10 Finland
Atrial septal defect NOS
70.2
51.9
59
9
XF404
NOMESCO Finland
Ambulatory ECG
4.5
49.7
136
345
APJ
HP
PFO closure
+∞
41.0
39
*
PA6BD
NOMESCO Finland
Extensive CT of neck arteries
7.3
40.8
62
91
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.3
39.3
181
651
Q21.08
ICD-10 Finland
Other specifed ventricular septal defect
11.3
35.7
38
35
G45.0
ICD-10 Finland
Vertebro-basilar artery syndrome
8.9
35.5
45
53
PA6AD
NOMESCO Finland
CT of neck arteries
5.4
32.5
67
133
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
5.7
32.4
62
115
Q25.0
ICD-10 Finland
Patent ductus arteriosus
11.4
32.2
34
31
PA7CD
NOMESCO Finland
CT angiography of neck and brain, extensive
12.3
30.9
31
26
I63
ICD-10 Finland
Cerebral infarction
36.0
29.9
38
11
FXA00
NOMESCO Finland
Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure
4.5
28.9
73
172
FFC00
NOMESCO Finland
Suture of ostium secundum type ASD
37.5
28.6
36
10
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
3.2
27.9
125
437
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
3.3
26.6
110
366
TFC00
NOMESCO Finland
Catheterisation of right atrium or ventricle
10.7
26.3
29
28
B01AB05
ATC
enoxaparin; parenteral
2.3
25.0
267
1427
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.3
24.4
239
1230
H53.4
ICD-10 Finland
Visual field defects
7.1
24.3
37
54
R42
ICD-10 Finland
Dizziness and giddiness
2.4
24.0
207
1008
WX408
NOMESCO Finland
General anesthesy, balanced
2.2
24.0
284
1579
TPH04
NOMESCO Finland
Cathetrisation of vein
2.3
23.9
224
1130
Z01.8
ICD-10 Finland
Other specified special examinations
2.3
23.7
234
1206
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
3.1
23.4
107
377
Q21.09
ICD-10 Finland
Ventricular septal defect NOS
20.8
23.2
34
17
AA1AG
NOMESCO Finland
Short MRI examination of brain with median intensity magnet
6.2
23.1
40
67
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.9
23.0
120
456
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
2.4
21.8
186
898
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.3
20.5
176
850
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
4.2
20.0
55
138
I35.1
ICD-10 Finland
Aortic (valve) insufficiency
3.9
19.5
59
159
XFE00
NOMESCO Finland
Epicardial ultrasonography
6.6
18.0
29
45
WX892
NOMESCO Finland
Monitored bed care
2.8
17.8
96
370
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
2.7
17.5
99
391
Q23.11
ICD-10 Finland
Bicuspid aortic valve
6.9
17.5
27
40
I48
ICD-10 Finland
Atrial fibrillation and flutter
2.4
17.4
138
640
I63.1
ICD-10 Finland
Cerebral infarction due to embolism of precerebral arteries
14.2
17.4
29
21
N18
ICPC
Paralysis/weakness
6.5
17.2
28
44
I71.2
ICD-10 Finland
Thoracic aortic aneurysm, without mention of rupture
4.9
16.7
37
78
Q21.29
ICD-10 Finland
Atrioventricular septal defect UNS
+∞
16.7
16
*
ZXE00
NOMESCO Finland
One hour or less
1.8
16.2
357
2395
FM1DG
NOMESCO Finland
Very extensive MRI examination of heart with high intesity magnet
5.1
15.6
33
67
FFC40
NOMESCO Finland
Closure of Patent Foramen Ovale
162.8
15.5
16
*
WX872
NOMESCO Finland
Intensive care
3.3
15.0
57
179
PA7BD
NOMESCO Finland
CT angiography of neck and brain
6.6
15.0
24
37
WX402
NOMESCO Finland
General anaesthesia
1.9
14.8
240
1454
E78.5
ICD-10 Finland
Hyperlipidaemia, unspecified
2.5
14.5
97
415
APK
HP
ASD closure
152.5
14.5
15
*
R20.2
ICD-10 Finland
Paraesthesia of skin
2.8
14.5
78
300
ZXE10
NOMESCO Finland
More than one and less than three hours
1.8
14.3
305
2010
FM2CE, ,
NOMESCO Finland
3.7
14.1
45
126
K78
ICPC
Atrial fibrillation/flutter
3.1
14.0
59
198
FN1BC
NOMESCO Finland
Extensive angiography of hear and/or coronary arteries
3.4
13.5
49
150
R1260
NOMESCO Finland
Evaluation of communicative skills
4.8
12.9
29
62
Q21.9
ICD-10 Finland
Congenital malformation of cardiac septum, unspecified
50.8
12.9
15
*
XFP20
NOMESCO Finland
Check up of cardiac pacemaker
3.1
12.5
54
184
AF1
HP
Surgery of congenital heart defect
47.3
11.9
14
*
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.7
11.9
377
2738
PA2BD
NOMESCO Finland
Extensive CT angiography of brain
5.2
11.8
24
47
31
HP
Congenital heart failure surgery
30.5
11.7
15
5
TPH07
NOMESCO Finland
Cathetrisation of artery
2.2
11.6
108
533
C10AX09
ATC
ezetimibe; oral
2.0
11.5
139
757
R47.0
ICD-10 Finland
Dysphasia and aphasia
10.7
11.3
21
20
I34.09
ICD-10 Finland
Mitral (valve) insufficiency
3.4
11.2
41
126
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
2.2
10.8
100
493
I36.1
ICD-10 Finland
Nonrheumatic tricuspid (valve) insufficiency
5.7
10.7
20
36
C09AA05
ATC
ramipril; oral
1.8
10.7
169
1005
XF402
NOMESCO Finland
ECG with work load test
2.3
10.6
80
362
TFB00
NOMESCO Finland
Cathetrisation of pulmonal artery
4.7
10.5
24
52
R4110
NOMESCO Finland
Physiotherapy
1.7
10.5
249
1664
PA2VT
NOMESCO Finland
Intravascular evacuation of brain artery embolus
12.2
10.4
18
15
XF600
NOMESCO Finland
Bloodpressure measurement
2.3
10.4
80
365
ZXY02
NOMESCO Finland
Neuropsychologist
8.9
10.3
21
24
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.3
10.2
83
387
SPAT1263
SPAT
Sampling
1.6
10.1
326
2352
R4130
NOMESCO Finland
Speech therapy
3.0
10.1
45
156
G43.9
ICD-10 Finland
Migraine, unspecified
2.4
9.9
71
313
K91
ICPC
Cerebrovascular disease
7.8
9.9
22
29
Q21.18
ICD-10 Finland
Other spedified atrial septal defect
26.3
9.8
13
5
B01AC07
ATC
dipyridamole; systemic
4.6
9.8
23
51
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
3.3
9.7
36
112
I63.8
ICD-10 Finland
Other cerebral infarction
9.2
9.6
19
21
PA6BG
NOMESCO Finland
MRI examination of neck vasculature with high intensity magnet
10.8
9.3
17
16
B01AF02
ATC
apixaban; oral
2.1
9.1
86
426
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.8
8.8
146
878
R06.0
ICD-10 Finland
Dyspnoea
1.7
8.7
205
1358
SPAT1224
SPAT
Implementation of speech therapy rehabilitation plan
3.5
8.7
30
89
G46.4*I67.9
ICD-10 Finland
Cerebellar stroke syndrome
27.8
8.5
11
*
XXA00
NOMESCO Finland
Clinical examination requiring general anaesthesia
7.4
8.5
19
26
TFC99
NOMESCO Finland
Catheterisation of heart with other procedure
8.6
8.3
17
20
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.6
8.3
229
1577
K89
ICPC
Transient cerebral ischaemia
9.6
8.3
16
17
H53.1
ICD-10 Finland
Subjective visual disturbances
2.3
8.2
65
300
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
1.7
8.2
171
1097
C07AB07
ATC
bisoprolol; oral
1.5
8.2
317
2361
SPAT1377
SPAT
Polysomnography
3.2
8.1
31
98
D68.8
ICD-10 Finland
Other specified coagulation defects
4.8
8.1
18
38
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
2.9
8.1
38
136
I63.0
ICD-10 Finland
Cerebral infarction due to thrombosis of precerebral arteries
9.0
8.1
16
18
J01CA04
ATC
amoxicillin; systemic
1.7
8.0
725
6484
351
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
2.0
7.9
86
450
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.3
7.9
59
266
WX882
NOMESCO Finland
High dependency care
2.4
7.9
53
228
C03CA01
ATC
furosemide; systemic
1.7
7.8
158
1002
SPAT1215
SPAT
Assessment of need for medical rehabilitation
2.9
7.8
36
128
AAL10
NOMESCO Finland
Intracranial endovascular thrombolysis
15.2
7.7
12
8
AP2
HP
Catheterization of the right side of the heart
45.4
7.7
9
*
FPK00
NOMESCO Finland
Implantation of electrocardiograph with loop recorder
9.0
7.6
15
17
WX723
NOMESCO Finland
CPAP therapy
2.5
7.5
46
190
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.6
7.4
193
1306
TFP20
NOMESCO Finland
Cardiodefibrillation
2.4
7.4
52
228
FKB10
NOMESCO Finland
Annuloplasty of mitral valve for insufficiency using ring
7.4
7.2
16
22
N02AJ06
ATC
codeine and paracetamol; systemic
1.5
7.1
334
2572
I48.0
ICD-10 Finland
Paroxysmal atrial fibrillation
2.2
7.1
58
272
Q22.1
ICD-10 Finland
Congenital pulmonary valve stenosis
10.1
7.0
13
13
I34.1
ICD-10 Finland
Mitral (valve) prolapse
3.2
7.0
27
86
G43.3
ICD-10 Finland
Complicated migraine
3.6
7.0
23
66
C10AA01
ATC
simvastatin; oral
1.5
6.9
226
1609
PA6AG
NOMESCO Finland
Limited MRI examination of neck vasculature with high intensity magnet
7.6
6.9
15
20
PA6CG
NOMESCO Finland
Extensive MRI examination of neck vasculature with high intensity magnet
13.9
6.9
11
8
XF640, ,
NOMESCO Finland
3.6
6.9
22
62
R51.80
ICD-10 Finland
Headache
1.7
6.9
153
994
ZXE17
NOMESCO Finland
Procedure duration 150 to 179 minutes
3.5
6.9
23
67
I49.5
ICD-10 Finland
Sick sinus syndrome
3.3
6.9
25
77
ZXE20
NOMESCO Finland
More than three and less than five hours
1.8
6.8
108
639
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
3.7
6.8
21
58
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.6
6.7
158
1042
I27.8
ICD-10 Finland
Other specified pulmonary heart diseases
22.7
6.7
9
*
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.3
6.7
50
226
R04.0
ICD-10 Finland
Epistaxis
2.2
6.7
58
279
G04BE03
ATC
sildenafil; oral
4.2
6.6
17
41
O99.4
ICD-10 Finland
Diseases of the circulatory system complicating pregnancy, childbirth and the puerperium
10.1
6.5
12
12
WW502
NOMESCO Finland
Autotransfusion
10.1
6.5
12
12
I48.9
ICD-10 Finland
Atrial fibrillation and atrial flutter, unspecified
2.3
6.5
46
203
207
Kela drug reimbursment
Chronic arrhythmias
1.9
6.5
84
467
Z73.3
ICD-10 Finland
Stress, not elsewhere classified
4.0
6.5
18
46
FM1CE
NOMESCO Finland
Ultrasound examination of heart through catheter
70.3
6.4
7
*
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.9
6.4
84
468
201
Kela drug reimbursment
Chronic cardiac insufficiency
2.5
6.4
39
161
K84
ICPC
Heart disease other
3.2
6.3
24
76
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
2.2
6.3
54
258
Q21.1
ICD-10 Finland
Atrial septal defect
+∞
6.3
6
*
Z45.0
ICD-10 Finland
Adjustment and management of cardiac devices
2.9
6.3
28
98
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.8
6.2
93
540
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
2.2
6.2
50
233
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.0
6.2
68
357
UDC00
NOMESCO Finland
Ear microscopy
2.0
6.2
65
336
I63.5
ICD-10 Finland
Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries
5.4
6.2
17
32
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
2.6
6.1
33
128
FPH96
NOMESCO Finland
Other removal of cardiac pacemaker or cardioverter-defibrillator
12.6
6.1
10
8
Q23.0
ICD-10 Finland
Congenital stenosis of aortic valve
12.6
6.1
10
8
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
3.2
6.0
23
73
Z2445
NOMESCO Finland
Psychologist
2.0
6.0
62
318
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
229
133
23.05
290.28
1.1
1.1
—
—
—
0
0
207
141
18.98
241.22
1.3
1.2
3.26
4.97
u/ml
0.48
97
62
195
138
17.95
222.10
1.3
1.2
2.92
2.35
u/ml
0.22
86
48
412
1182
5.75
142.20
3.4
3.8
30.57
29.86
s
1.02
406
1161
669
2974
6.51
134.44
24.2
11.8
1.38
1.19
inr
12.74
560
2454
503
2073
4.41
102.10
2.8
2.2
148.17
267.49
u/l
1.76
490
1978
80
46
19.06
99.26
1.1
1.1
1.06
1.06
ratio
0.00
73
41
477
1979
4.14
93.86
5.2
5.8
85.25
90.55
%
4.83
472
1953
405
1827
3.29
63.81
2.4
2.7
—
—
—
0
0
575
3373
3.10
54.14
3.1
3.0
—
—
estimate
—
0
0
375
1771
2.97
52.16
4.1
3.8
745.23
1069.27
ng/l
1.60
296
1480
673
4377
3.42
51.76
6.8
6.7
6.04
6.52
mmol/l
14.12
652
4163
462
2472
2.86
50.38
4.3
3.5
32.78
60.96
ng/l
0.55
336
1603
141
485
3.28
32.57
3.8
4.1
1.23
1.23
mmol/l
0.09
134
425
38
44
8.99
30.34
1.2
1.1
—
—
—
0
0
164
644
2.91
29.97
3.5
3.1
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
79
210
4.04
26.71
6.6
7.9
0.49
0.33
iu/ml
3.81
54
110
703
5510
2.47
24.20
5.0
4.4
7.51
10.04
mm/h
8.62
673
5210
534
3779
2.08
23.38
13.1
12.2
0.00
0.00
e9/l
0.50
418
3021
117
449
2.86
21.97
3.8
3.9
173.41
166.66
ng/l
0.05
96
410
235
1260
2.19
21.35
6.5
6.5
0.82
0.82
mmol/l
0.19
227
1213
481
3382
1.95
20.21
10.5
9.7
1.21
1.22
mmol/l
0.54
454
3180
841
7506
5.34
18.14
18.9
14.9
20.50
23.00
mg/l
1.64
702
5986
837
7468
4.73
17.55
22.9
17.3
3.96
3.97
mmol/l
0.84
832
7323
594
4603
1.93
17.35
8.4
11.4
3.85
3.94
e9/l
0.39
493
3962
215
1223
2.01
16.12
7.8
9.4
1.11
1.15
mmol/l
1.34
204
1163
500
3726
1.81
15.89
11.1
9.7
1.21
1.21
mmol/l
0.44
389
3311
273
1721
1.86
14.87
3.0
2.5
1.04
1.38
mg/l
0.90
205
1337
636
5210
1.83
13.59
4.2
3.8
36.44
45.93
u/l
5.68
611
5013
773
6812
2.27
12.71
5.6
5.0
1.87
1.89
mu/l
0.18
735
6412
215
1315
1.84
12.60
4.1
3.8
884.96
605.80
ng/l
0.68
154
936
317
2188
1.71
12.18
3.6
2.9
0.00
0.05
estimate
0.63
130
620
749
6568
2.05
11.73
17.2
13.3
86.24
87.03
ml/min/173m2
0.49
691
5958
296
2042
1.68
11.19
3.8
3.6
0.01
0.01
estimate
0.15
144
714
751
6620
2.02
11.16
5.1
4.1
1.16
1.30
mmol/l
8.45
707
6237
742
6542
1.94
10.60
5.9
5.8
37.34
38.69
mmol/mol
6.16
706
6231
558
4593
1.61
9.76
5.2
4.3
369.25
780.42
e6/l
—
8
71
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
22
53
4.23
8.49
1.6
1.9
146.14
131.66
%
0.33
22
53
769
6977
1.92
8.41
6.1
4.9
4.18
4.66
mmol/l
35.47
733
6639
390
3034
1.52
8.20
6.0
6.5
36.51
36.46
g/l
0.06
358
2897
127
750
1.81
8.09
5.3
4.5
36.18
31.30
%
4.97
97
533
69
330
2.19
8.01
1.4
1.9
4.42
7.62
iu/ml
—
8
75
764
6952
1.85
7.78
6.1
4.7
1.41
1.43
mmol/l
0.83
729
6577
660
5806
1.58
7.36
4.5
4.2
14.52
14.57
pmol/l
0.23
612
5402
143
899
1.71
7.31
1.9
1.7
1280.22
1175.37
nmol/l
0.61
105
701
232
1648
1.56
7.24
3.3
3.0
5.12
5.97
e6/l
0.40
209
1491
483
3989
1.48
7.23
4.0
3.6
0.02
0.43
estimate
0.48
143
710
476
3933
1.47
7.03
3.9
3.6
0.00
0.00
estimate
0.50
143
761
766
7022
1.79
6.97
6.6
5.3
2.38
2.77
mmol/l
30.21
734
6664
479
3970
1.46
6.91
3.9
3.6
9.53
6.25
estimate
0.13
145
765
172
1151
1.62
6.88
2.0
2.1
—
—
—
0
0
371
2941
1.46
6.69
3.6
3.3
0.00
0.02
estimate
1.73
124
642
382
3062
1.44
6.41
2.1
2.0
1.23
1.40
mmol/l
3.17
299
2679
98
574
1.80
6.39
2.2
2.3
25.47
18.18
au/ml
—
10
62
36
145
2.55
6.18
3.2
3.0
16.99
16.82
%
0.13
36
139
48
222
2.23
6.08
1.1
2.8
3.65
3.55
mmol/l
0.39
43
212
730
6671
1.60
5.92
5.0
4.6
5.67
5.86
mmol/l
4.79
667
6244
282
2166
1.45
5.82
3.6
3.6
0.23
0.36
e6/l
0.73
212
1549
89
524
1.78
5.71
1.2
1.3
28.90
53.20
au/ml
—
6
42
297
2332
1.42
5.34
3.4
3.5
2.35
2.36
mmol/l
0.74
268
2161
252
1922
1.44
5.32
3.1
2.6
3.05
2.73
mg/l
1.12
221
1699
239
1808
1.44
5.26
1.6
1.6
19.51
20.27
nmol/l
0.35
181
1575
617
5494
1.43
5.23
8.4
8.2
84.76
87.75
u/l
0.59
582
5254
288
2262
1.41
5.13
2.5
2.9
56.93
62.53
u/l
1.00
257
2140
18
55
3.32
5.04
1.8
1.5
47.15
57.86
%
0.55
13
43
818
7773
1.96
4.94
13.9
11.8
28.02
27.89
u/l
0.05
801
7610
855
8280
3.81
4.90
29.6
22.6
250.54
256.14
e9/l
1.63
841
8101
855
8286
3.75
4.77
29.6
22.5
4.55
4.58
e12/l
1.11
840
8082
33
145
2.33
4.76
5.7
4.4
6.60
7.82
pmol/l
0.67
33
145
44
218
2.07
4.74
1.2
3.0
16.97
13.23
e6/l
0.12
34
155
41
198
2.12
4.72
2.3
1.7
—
—
—
0
0
308
2475
1.38
4.71
3.9
3.7
31.61
78.93
e6/l
0.95
237
1859
24
91
2.68
4.68
1.1
1.1
—
—
—
0
0
44
221
2.04
4.58
1.3
3.0
123.80
596.65
e6/l
0.69
35
165
19
65
2.97
4.46
1.0
1.0
—
—
—
0
0
437
3739
1.34
4.35
7.3
7.7
13.86
14.35
umol/l
0.16
406
3590
25
102
2.49
4.24
4.2
5.0
90.76
98.14
%
0.67
25
102
436
3754
1.33
4.05
4.2
3.4
79.44
115.33
ug/l
6.73
390
3572
24
99
2.46
4.00
1.1
1.1
—
—
—
0
0
16
53
3.06
3.98
1.3
1.8
—
—
—
0
0
18
64
2.85
3.97
2.1
2.4
57.60
21.04
mg/l
—
5
30
82
524
1.62
3.94
1.9
3.0
65.45
66.55
g/l
0.74
76
497
43
228
1.93
3.89
1.3
1.3
13.88
10.10
u/ml
—
5
35
338
2820
1.33
3.87
2.1
2.0
97.86
96.56
pmol/l
0.22
180
1530
119
834
1.49
3.81
13.2
7.9
1.61
1.18
mmol/l
1.11
95
625
110
761
1.51
3.75
13.3
11.5
0.45
0.63
mmol/l
0.20
93
651
145
1062
1.44
3.71
3.2
3.0
21.08
23.83
%
1.87
127
1012
38
198
1.96
3.63
1.3
2.3
0.22
0.95
g/l
1.69
32
183
19
74
2.60
3.57
3.0
2.7
0.88
0.94
nmol/l
0.19
13
61
164
1239
1.40
3.52
3.2
2.9
12.35
13.97
umol/l
2.22
147
1176
154
1151
1.41
3.52
3.1
3.0
2.48
2.37
g/l
1.72
136
1089
166
1260
1.39
3.47
1.8
1.7
444.42
21878276.02
pmol/l
0.99
118
1097
121
872
1.45
3.37
1.8
2.0
—
—
—
0
0
74
483
1.58
3.29
2.5
2.3
14.81
8.13
ug/l
1.40
65
437
160
1222
1.38
3.21
3.0
3.0
152.28
99.17
ug/g
0.51
127
1005
12
34
3.56
3.20
4.8
9.6
4.72
4.89
kpa
0.44
12
34
21
92
2.31
3.12
2.8
2.5
30.71
33.35
pg
1.41
21
92
42
239
1.80
3.11
1.2
1.2
—
2.26
—
0
7
8
16
5.04
3.05
1.5
1.8
—
—
—
0
0
95
668
1.47
3.01
5.0
6.3
—
—
—
0
0
19
81
2.38
3.00
4.9
3.0
1.68
1.97
umol/l
0.95
19
75
29
148
1.99
2.98
1.6
2.0
—
—
—
0
0
114
838
1.41
2.87
1.9
2.0
—
—
—
0
0
177
1398
1.33
2.85
1.4
1.3
14.94
31.22
iu/ml
4.80
47
400
13
47
2.79
2.82
1.0
1.0
0.94
1.23
u/l
—
5
24
48
293
1.68
2.81
1.6
2.3
1.38
1.39
g/l
0.03
39
267
12
39
3.11
2.78
1.0
1.1
1408.92
1665.69
miu/ml
0.48
12
39
5
6
8.37
2.75
1.2
1.2
—
—
—
0
0
5
6
8.37
2.75
2.0
19.2
—
—
—
0
0
68
455
1.54
2.74
1.4
1.8
—
—
—
0
0
6
10
6.03
2.70
1.2
1.3
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
12
40
3.03
2.70
1.8
1.2
75.67
106.52
%
1.62
12
40
96
692
1.44
2.69
1.2
1.4
202.13
294.07
u/ml
0.47
90
647
41
243
1.72
2.68
2.2
2.0
—
—
—
0
0
27
140
1.96
2.67
1.6
1.4
—
—
—
0
0
39
228
1.74
2.67
2.2
1.9
—
—
—
0
0
35
201
1.77
2.56
1.4
2.6
—
—
—
0
0
15
62
2.44
2.55
1.2
1.1
0.46
0.52
ratio
—
10
36
27
145
1.89
2.44
1.4
2.0
—
—
—
0
0
24
124
1.96
2.42
1.3
1.8
—
—
—
0
0
376
3320
1.23
2.41
3.4
2.9
73.63
74.07
nmol/l
0.12
341
3064
42
259
1.65
2.40
1.7
2.0
—
—
—
0
0
5
8
6.28
2.37
1.2
1.5
—
—
—
0
0
23
118
1.97
2.37
6.8
7.2
12.41
10.53
mg/l
0.63
18
110
29
162
1.82
2.33
1.6
1.6
—
—
—
0
0
45
285
1.61
2.33
1.3
1.5
0.22
0.23
g/l
0.30
45
277
12
47
2.57
2.27
1.3
1.1
—
—
—
0
0
6
13
4.64
2.27
1.2
1.1
—
—
—
0
0
6
13
4.64
2.27
3.0
4.1
4.38
4.56
mmol/l
—
6
13
262
2239
1.24
2.24
1.6
1.6
0.97
2.31
u/ml
2.60
75
567
42
265
1.61
2.21
1.7
2.2
—
—
—
0
0
5
9
5.58
2.21
2.6
14.9
34.80
25.33
mg/l
—
5
9
37
226
1.67
2.21
1.6
1.4
307.92
314.18
ug/g
0.07
22
133
36
221
1.66
2.12
2.4
2.8
—
—
—
0
0
30
175
1.74
2.12
3.4
2.7
133.79
131.75
g/l
0.19
24
142
149
1198
1.29
2.11
2.6
2.7
2.42
2.44
mmol/l
1.27
135
1075
8
25
3.22
2.10
2.3
1.8
—
—
—
0
0
158
1282
1.28
2.09
1.4
1.3
7.46
11.20
u/ml
0.29
54
501
6
15
4.02
2.04
2.0
3.3
94.50
98.73
g/l
—
6
15
12
50
2.42
2.03
1.4
1.5
—
—
—
0
0
14
63
2.24
2.01
1.1
1.1
—
79.00
—
0
6
34
209
1.65
2.00
1.6
1.7
—
—
—
0
0
108
837
1.33
2.00
4.4
5.3
262.82
263.46
u/l
0.01
99
807
217
1839
1.24
1.98
3.2
3.3
335.11
337.44
umol/l
0.16
187
1686
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
14
64
2.21
1.95
1.2
1.2
—
—
—
0
0
29
174
1.69
1.88
1.6
2.1
—
—
—
0
0
8
28
2.87
1.86
1.1
1.2
—
—
—
0
0
8
28
2.87
1.86
1.1
1.1
—
—
—
0
0
11
46
2.41
1.85
2.0
2.4
520.00
593.00
ml
—
6
27
19
101
1.90
1.82
1.1
1.0
—
—
—
0
0
41
273
1.53
1.77
1.6
1.7
22.40
7.57
u/ml
—
8
68
12
54
2.24
1.74
2.5
3.1
1.00
2.08
u/field
—
6
36
5
13
3.86
1.71
1.2
1.1
—
—
—
0
0
119
956
1.28
1.71
4.8
4.6
5.56
8.16
umol/l
2.53
103
840
6
19
3.17
1.66
7.7
14.6
10.72
10.35
%
—
6
19
39
261
1.52
1.66
2.2
2.1
2.08
2.22
ug/l
0.04
30
239
10
41
2.46
1.64
1.2
1.9
—
—
—
0
0
72
545
1.35
1.59
2.0
1.8
21.68
22.45
iu/l
0.08
59
423
22
129
1.72
1.58
1.1
1.1
1.44
1.47
g/l
0.16
22
120
13
64
2.05
1.54
1.2
1.2
—
—
—
0
0
77
592
1.33
1.54
6.6
6.1
67.03
74.57
ng/l
0.59
66
542
26
161
1.63
1.54
1.3
1.7
—
—
—
0
0
7
27
2.60
1.51
1.1
1.7
90.86
102.65
ng/l
—
7
27
27
170
1.61
1.50
1.2
1.2
—
—
—
0
0
20
116
1.74
1.49
1.6
1.3
—
—
—
0
0
13
65
2.02
1.49
4.3
4.7
1.62
0.74
index
0.88
13
65
10
45
2.24
1.46
1.2
1.8
—
—
—
0
0
7
28
2.51
1.45
1.1
1.2
—
—
—
0
0
235
2067
1.19
1.45
1.6
1.6
2.05
2.18
g/l
0.70
152
1253
5
16
3.14
1.44
1.0
1.2
—
—
—
0
0
12
59
2.05
1.44
1.2
1.2
—
—
—
0
0
79
617
1.31
1.43
17.6
8.6
9.16
9.36
kpa
0.48
79
601
26
165
1.59
1.41
1.6
1.3
—
—
—
0
0
63
477
1.35
1.41
18.3
13.6
1.08
1.28
%
1.90
63
472
15
81
1.87
1.40
1.0
1.2
—
—
—
0
0
9
40
2.26
1.40
1.2
1.9
—
—
—
0
0
7
29
2.42
1.39
2.9
2.5
13.51
19.71
umol/l
—
7
29
150
1746
0.83
1.29
3.8
3.6
1.02
1.02
kg/l
0.21
103
1147
76
601
1.29
1.28
1.4
1.3
81.66
145.29
u/ml
1.17
24
233
24
154
1.57
1.27
1.1
1.2
—
—
—
0
0
31
211
1.49
1.27
2.9
3.5
6.00
2.73
index
0.53
17
125
55
416
1.34
1.26
1.8
1.7
—
—
—
0
0
15
85
1.78
1.23
1.1
1.3
—
—
—
0
0
18
108
1.68
1.23
1.7
2.3
—
2306.67
—
0
6
20
124
1.63
1.21
1.5
1.9
—
—
—
0
0
31
214
1.47
1.19
2.0
2.0
3.47
4.70
iu/l
—
10
85
254
2284
1.16
1.18
5.4
4.6
1.68
1.96
ug/l
0.61
211
2104
31
215
1.46
1.17
1.4
1.3
—
—
—
0
0
60
468
1.30
1.13
3.3
3.6
4.68
4.71
pmol/l
0.07
51
420
17
103
1.66
1.13
1.5
2.0
—
—
—
0
0
16
96
1.68
1.10
1.1
1.4
347.89
513.17
pmol/l
—
9
88
69
551
1.27
1.10
3.5
2.6
68.76
72.15
ml/min/173m2
0.24
29
236
222
1988
1.16
1.08
1.8
1.8
—
—
—
0
0
10
52
1.93
1.06
1.5
1.4
23386.00
32403.92
e6/l
—
5
26
7
34
2.07
1.03
8.0
7.6
2.02
2.22
mg/l
—
7
27
7
35
2.01
1.00
1.0
1.3
—
—
—
0
0
7
35
2.01
1.00
1.0
1.3
—
—
—
0
0
45
346
1.32
0.97
1.9
1.7
—
—
—
0
0
53
419
1.28
0.94
3.2
7.4
0.64
0.60
%
0.34
53
419
120
1038
1.18
0.92
7.4
8.1
1.41
1.31
mmol/l
0.11
101
879
47
367
1.30
0.92
1.9
2.3
13532.76
5110.23
u/l
0.65
17
143
19
127
1.51
0.89
1.0
1.1
3.14
5.82
iu/ml
—
5
26
86
727
1.20
0.86
2.7
2.6
57.31
99.53
u/l
0.27
75
615
10
57
1.76
0.84
2.0
1.9
—
—
—
0
0
10
57
1.76
0.84
1.6
1.4
1406.60
3158.86
e6/l
—
5
35
45
355
1.28
0.83
1.2
1.1
1.45
1.49
g/l
0.57
45
355
8
47
1.71
0.81
1.0
1.1
184.54
218.25
iu/ml
—
8
47
46
366
1.27
0.80
1.2
1.2
0.78
0.91
g/l
2.42
46
366
6
33
1.82
0.79
1.2
1.5
—
—
—
0
0
0
25
0.00
0.79
0.0
1.2
—
8.52
—
0
14
8
48
1.67
0.79
1.0
1.0
38.13
48.95
iu/ml
—
8
48
0
26
0.00
0.78
0.0
3.2
—
29.42
—
0
26
6
34
1.77
0.76
1.2
1.2
110.00
108.41
%
—
6
29
16
232
0.68
0.75
1.4
1.4
—
—
—
0
0
5
25
2.01
0.72
1.0
1.1
—
—
—
0
0
25
185
1.36
0.72
2.2
1.6
21.30
23.02
ng/l
0.17
25
185
91
1046
0.85
0.72
1.5
1.5
—
—
—
0
0
43
346
1.26
0.70
1.2
1.3
—
—
—
0
0
5
27
1.86
0.68
5.2
7.5
—
1362814.29
—
0
7
5
27
1.86
0.68
4.8
7.5
—
—
—
0
0
7
43
1.63
0.67
1.0
1.1
—
—
—
0
0
5
28
1.79
0.66
1.4
1.1
—
—
—
0
0
5
28
1.79
0.66
1.4
1.1
—
—
—
0
0
5
28
1.79
0.66
1.2
1.3
—
—
—
0
0
5
28
1.79
0.66
1.4
2.1
—
—
—
0
0
5
28
1.79
0.66
1.4
2.1
—
—
—
0
0
8
128
0.62
0.64
1.1
1.3
—
—
—
0
0
5
29
1.73
0.64
1.4
2.0
—
—
—
0
0
5
29
1.73
0.64
1.0
1.2
—
—
—
0
0
5
29
1.73
0.64
1.0
1.2
—
—
—
0
0
121
1082
1.14
0.63
1.8
2.1
—
—
—
0
0
67
573
1.18
0.63
3.8
4.7
3.01
20.03
ug/l
1.24
54
462
8
50
1.61
0.61
2.0
4.1
537.63
752.22
u/ml
—
8
50
24
183
1.32
0.60
1.3
1.4
—
—
—
0
0
24
183
1.32
0.60
1.3
1.4
—
—
—
0
0
99
1113
0.88
0.60
1.4
1.9
1.34
1.45
%
1.28
89
984
12
174
0.69
0.59
1.1
1.1
1.34
2.94
eliau/ml
—
5
69
64
549
1.18
0.59
1.3
1.5
—
—
—
0
0
14
98
1.44
0.56
1.5
1.2
—
—
—
0
0
129
1169
1.12
0.56
1.9
2.2
—
—
—
0
0
11
160
0.68
0.56
1.8
1.8
—
—
—
0
0
10
65
1.54
0.55
2.0
2.4
—
—
—
0
0
6
37
1.63
0.55
1.7
1.9
—
—
—
0
0
6
37
1.63
0.55
1.7
1.9
—
—
—
0
0
6
37
1.63
0.55
1.7
1.9
—
—
—
0
0
6
37
1.63
0.55
1.7
1.9
—
—
—
0
0
41
340
1.22
0.54
1.2
1.1
0.68
0.67
ratio
—
6
35
13
182
0.71
0.54
1.9
1.7
—
—
—
0
0
9
60
1.50
0.54
1.3
1.2
200.20
166.24
pmol/l
—
9
60
6
38
1.58
0.54
1.2
1.3
—
60.00
—
0
6
9
62
1.46
0.53
1.1
1.2
—
—
—
0
0
9
63
1.43
0.52
1.1
1.2
—
—
—
0
0
96
860
1.13
0.51
2.8
2.3
12.20
12.89
nmol/l
0.38
86
788
152
1401
1.10
0.49
3.2
2.9
0.78
0.72
ug/l
0.17
91
789
283
2685
1.08
0.48
4.2
3.9
33.52
34.10
u/l
0.07
265
2572
13
93
1.40
0.48
1.1
1.3
—
—
—
0
0
13
93
1.40
0.48
1.1
1.3
—
—
—
0
0
263
2490
1.08
0.47
3.7
3.8
8.18
8.18
mmol/l
0.00
205
2190
30
245
1.23
0.47
1.1
1.1
6.96
18.54
au/ml
—
8
50
11
154
0.71
0.47
1.2
1.7
—
—
—
0
0
5
83
0.60
0.46
1.2
1.3
—
112.31
—
0
13
10
69
1.45
0.44
1.3
1.1
—
—
—
0
0
5
31
1.62
0.43
1.2
1.9
—
—
—
0
0
10
139
0.72
0.42
1.7
1.6
60.00
54.58
ug/l
—
10
139
28
232
1.21
0.40
1.1
1.1
12.45
9.46
u/ml
0.24
15
126
12
88
1.37
0.40
1.1
1.4
—
—
—
0
0
12
88
1.37
0.40
1.1
1.4
—
—
—
0
0
27
224
1.21
0.38
1.3
1.3
—
—
—
0
0
18
225
0.80
0.38
1.1
1.1
—
—
—
0
0
18
225
0.80
0.38
1.1
1.1
—
—
—
0
0
5
36
1.39
0.38
1.0
1.1
115.22
33.13
u/ml
—
5
36
12
89
1.35
0.38
1.1
1.3
—
—
—
0
0
14
107
1.31
0.37
1.4
1.5
—
—
—
0
0
25
300
0.83
0.37
1.5
1.4
—
—
—
0
0
574
5618
1.06
0.37
3.6
3.4
—
—
—
0
0
140
1308
1.08
0.36
3.4
3.4
2.73
1.72
e6/l
0.99
63
637
16
201
0.79
0.36
3.1
4.4
1.23
1.36
mmol/l
0.35
16
195
12
91
1.32
0.34
1.1
1.3
—
—
—
0
0
40
351
1.15
0.32
1.1
1.2
1.22
1.78
u/ml
0.34
22
228
41
361
1.14
0.32
1.3
1.4
—
—
—
0
0
33
379
0.87
0.31
1.4
1.6
1361.58
936.28
mu/l
0.73
25
324
7
55
1.27
0.30
1.1
1.2
—
—
—
0
0
19
157
1.21
0.29
1.8
1.5
—
—
—
0
0
50
554
0.90
0.29
1.8
2.1
—
—
—
0
0
14
112
1.25
0.28
1.8
4.4
—
—
—
0
0
145
1374
1.07
0.27
2.9
3.3
1.00
0.81
e6/l
0.19
72
698
8
67
1.20
0.26
1.0
1.2
105.13
113.27
pmol/l
—
8
67
23
266
0.86
0.25
1.0
1.1
0.62
7.87
eliau/ml
—
6
45
39
434
0.89
0.25
1.4
1.3
—
—
—
0
0
28
246
1.14
0.24
1.1
1.1
12.20
7.54
u/ml
0.30
14
147
218
2102
1.05
0.23
4.4
4.2
99.71
9.21
mg/mmol
0.50
123
1360
22
190
1.16
0.23
1.4
1.5
—
—
—
0
0
28
316
0.88
0.22
1.3
1.3
191.21
243.51
miu/ml
0.37
11
153
13
157
0.83
0.22
1.3
1.4
41.48
162.71
pmol/l
1.03
13
151
103
974
1.07
0.22
2.2
2.0
3.18
3.59
ratio
1.90
79
763
5
41
1.22
0.22
1.0
1.2
0.43
3.84
u/ml
—
5
35
5
41
1.22
0.22
5.2
5.4
—
—
—
0
0
5
41
1.22
0.22
1.2
1.1
—
—
—
0
0
5
41
1.22
0.22
9.6
9.5
—
491.33
—
0
6
5
42
1.19
0.21
1.6
1.4
—
—
—
0
0
0
10
0.00
0.21
0.0
2.5
—
68.94
—
0
10
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
1.6
—
1.18
—
0
12
0
12
0.00
0.21
0.0
6.0
—
—
—
0
0
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
33
297
1.12
0.20
2.1
1.8
328.68
196.25
u/ml
1.35
19
163
26
231
1.13
0.19
1.3
1.6
—
—
—
0
0
6
50
1.20
0.19
1.0
1.5
93.50
75.50
umol/l
—
6
50
61
569
1.08
0.19
1.0
1.1
—
—
—
0
0
22
249
0.88
0.19
1.4
1.5
—
—
—
0
0
30
332
0.90
0.19
1.8
2.0
7.63
3.85
mg/l
0.38
16
249
6
53
1.13
0.18
1.7
1.6
2.67
5.20
u/l
—
6
45
29
261
1.11
0.18
2.0
1.9
118.11
124.10
au/ml
—
9
103
10
82
1.22
0.17
1.4
1.1
—
—
—
0
0
38
411
0.92
0.16
1.4
1.7
0.30
0.32
mg/l
0.06
15
191
69
728
0.94
0.15
1.8
1.7
2.83
3.47
mmol/l
4.33
47
513
62
656
0.94
0.15
2.0
2.2
—
—
—
0
0
34
313
1.09
0.15
1.1
1.2
3.96
2.73
u/ml
0.23
19
203
7
86
0.81
0.14
1.0
1.0
—
—
—
0
0
34
314
1.09
0.14
1.1
1.2
0.82
1.02
u/ml
0.16
18
192
10
84
1.19
0.14
1.5
1.2
—
—
—
0
0
8
99
0.81
0.13
3.1
1.5
—
—
—
0
0
38
355
1.07
0.12
7.0
4.2
55.04
51.26
%
0.36
38
350
12
104
1.16
0.12
4.2
1.4
0.58
0.54
nmol/l
0.25
12
97
44
414
1.07
0.12
2.3
2.0
6.03
7.56
u/l
0.43
33
285
10
85
1.18
0.12
1.5
1.1
—
—
—
0
0
59
563
1.05
0.11
1.4
1.2
—
2.90
—
0
5
10
86
1.16
0.11
1.5
1.2
—
—
—
0
0
21
192
1.10
0.11
1.4
1.5
1.22
1.18
ratio
—
8
118
21
192
1.10
0.11
1.4
1.5
1.21
1.14
ratio
—
8
118
21
192
1.10
0.11
1.4
1.5
0.99
0.96
ratio
—
8
118
34
320
1.06
0.09
1.1
1.2
6.39
5.74
u/ml
0.08
18
216
31
330
0.94
0.09
1.4
1.8
—
—
—
0
0
5
48
1.04
0.09
1.2
1.4
536.10
527.94
u/l
—
5
48
11
97
1.14
0.09
1.1
1.4
4.00
8.06
u/ml
—
5
64
21
226
0.93
0.08
1.2
1.4
—
—
—
0
0
15
164
0.91
0.08
3.6
3.2
1.27
2.54
ratio
—
8
89
8
90
0.89
0.06
1.1
1.8
—
—
—
0
0
14
152
0.92
0.06
3.1
2.5
31.83
95.71
ug/min
—
6
92
23
217
1.06
0.06
1.0
1.1
2.22
1.12
u/ml
0.21
12
100
10
90
1.11
0.05
1.5
1.1
—
—
—
0
0
58
566
1.03
0.04
3.9
2.8
0.13
0.19
e6/l
0.45
58
539
35
338
1.04
0.04
1.2
1.1
2.77
4.41
—
6
36
20
192
1.04
0.02
1.0
1.1
1.16
2.07
—
5
26
24
248
0.97
0.02
14.0
10.1
114.80
323.67
iu/ml
—
5
39
181
1800
1.01
0.01
3.7
3.9
21.64
21.64
%
0.00
82
745
11
110
1.00
0.00
1.7
1.5
24.19
4.35
ug/l
0.71
11
96
14
144
0.97
0.00
3.9
5.8
343.14
378.22
umol/l
0.50
14
131
14
141
0.99
0.00
1.1
1.1
—
1.04
—
0
9
13
129
1.01
0.00
1.0
1.1
17.30
15.77
u/ml
—
6
43
21
212
0.99
0.00
1.4
1.6
75.39
61.43
ug/l
0.50
14
182
12
124
0.97
0.00
1.4
1.3
—
—
—
0
0
7
70
1.00
0.00
1.0
4.2
—
—
—
0
0
7
70
1.00
0.00
1.0
4.2
—
—
—
0
0
7
69
1.01
0.00
1.6
1.7
—
—
—
0
0
7
69
1.01
0.00
1.6
1.7
—
—
—
0
0
7
69
1.01
0.00
1.6
1.7
—
—
—
0
0
7
70
1.00
0.00
2.1
1.9
—
—
—
0
0
5
55
0.91
-0.00
1.0
1.0
167.40
165.65
g/l
—
5
55
5
58
0.86
-0.00
1.0
1.4
5.64
10.31
u/ml
—
5
52
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
5.2
—
435.60
—
0
5
5
49
1.02
-0.00
1.2
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.6
—
—
—
0
0
0
7
0.00
-0.00
0.0
4.3
—
5.16
—
0
7
9
94
0.96
-0.00
5.1
1.4
0.16
0.18
nmol/l
—
9
70
0
6
0.00
-0.00
0.0
10.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.5
—
6.01
—
0
8
0
8
0.00
-0.00
0.0
3.1
—
0.50
—
0
8
0
5
0.00
-0.00
0.0
1.8
—
424.40
—
0
5
0
9
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.6
—
—
—
0
0
5
52
0.96
-0.00
2.0
2.9
—
64094.71
—
0
7
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: Q17_PATENT_FORAMEN_OVALE – Patent foramen ovale
GWS hits: -
This endpoint is excluded (different definition than used in FinnGen).